Answer
The prescriber must assess the severity. Severe kidney disease affects product selection, while use should be avoided in severe hepatic impairment.
Sources for this answer
- AQUIPTA 10 mg tabletsemc · SmPC Current selected SmPC · Version 4
loading page…